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Background: As one of the natural perturbants, infection with cytomegalovirus (CMV) is believed to
play a role in the development of Type I diabetes. Using the DP-BB rat model for autoimmune diabetes,
we here report about possible mechanisms responsible for R(at)CMV-induced accelerated onset of
diabetes.
Methods: Rats were i.p. infected with 2 £ 10
6plaque forming units (pfu) RCMV and followed for
diabetes development. Presence of RCMV antigens and DNA was analyzed by immunohistochemistry
and PCR on pancreatic tissueand isolated islets. The effect ofviral infection on peritoneal macrophages
(pMF) and diabetes development was studied by analyzing numbers of pMF, virus permissiveness and
by depletion of this subset by peritoneal lavage.
Results: RCMV accelerated onset of diabetes without infecting pancreatic islets. Immunohisto-
chemistry and PCR on pancreas and isolated islets indicated that islets are non-permissive for RCMV.
Infection results in an inﬂux of pMF 1 day p.i. of which ,0.05% showed signs of reproductive
infection. Depletion of pMF on days 1–3 p.i. completely counteracted the accelerating effect of
RCMV.
Interpretation: RCMV accelerates onset of diabetes without infecting pancreatic islets. pMF might
function as an carriage to disseminate virus to the pancreas where they enhance activation of
autoreactive T cells resulting in accelerated onset of diabetes.
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INTRODUCTION
Type 1 diabetes or Insulin Dependent Diabetes Mellitus
(IDDM) (accounting for 10% of all cases of diabetes) is an
organ-speciﬁc autoimmunedisease,which resultsfromthe
selectivedestructionofpancreaticb-cells.Thisdestruction
is histologically characterized by an inﬂammatory
inﬁltrate around or within the islets (insulitis) containing
large numbers of mononuclear cells and CD8
þ T cells
(Notkins and Lernmark, 2001). Clinically, Type 1 diabetes
presents as rapid onset polyuria, polydipsia, polyphagia,
weight loss and hyperglycaemia (Greiner et al., 2001).
Although genetic factors are believed to be an important
component in the pathogenesis of Type 1 diabetes (She,
1996; Field, 2002), also non-genetic factors appear to be
required for disease onset since concordance rates among
identical twins are only 30–50% (Redondo et al., 2001).
Among the non-genetic factors, viral infections are one of
the leading candidate agents involved in the pathogenesis
of Type 1diabetes and a variety of different humanviruses
have been reported to be associated with human Type 1
diabetes, including CoxsackieB virus, rubella virus,
mumps virus and several Herpesviridae (Jun and Yoon,
2001). Cytomegalovirus (CMV), a double stranded DNA
virus belonging to the b-herpes virus family, is one of the
Herpesviridae thought to be involved in the pathogenesis
of Type 1 diabetes. This widespread virus (seropositivity
varies from 60 to 90%) (Numazaki, 1997) causes latent
and persistent infection without clinical symptoms in the
immunocompetent host. In the immunocompromised host,
however, primary infections and reactivation of the virus
may cause severe morbidity and mortality (Alford and
Britt, 1990; Sinzger and Jahn, 1996). In the past decades,
several reports have suggested the existence of a
relationship between CMV infection and the development
of Type 1 diabetes in humans (Ward et al., 1979; Jenson
et al., 1980; Pak et al., 1988). To date, however, a causal
relationship between CMV infection and the development
of human Type 1 diabetes is still to be shown. Studies on
the relationship between CMV and Type I diabetes in
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CMV infection usually occurs at childhood and that Type
I diabetes is a disease of slow evolution in which the
pathogenetic process might already start years before
clinical diagnosis (Tarn et al., 1987; Foulis et al., 1997).
Recently, we were able to show a causal relationship
between CMV-infection and the development of
Type I diabetes using a well-established model of
autoimmune diabetes in rats. Infection of Diabetes Prone
(DP)-BB rats, which develop autoimmune diabetes
spontaneously at the age of 10–14 weeks (Mordes et al.,
2001), with RatCytomegalovirus (RCMV, e.g. the rat
equivalent of Human CMV (Bruggeman et al., 1982;
1985b)), resulted in signiﬁcant acceleration of the onset of
diabetes (J.L. Hillebrands, submitted).
Here,wereportonthepossibleunderlyingmechanismof
RCMV-induced acceleration of onsetof diabetes inDP-BB
rats. We ﬁrst analyzed whether RCMV can be detected in
pancreatic tissue and isolated pancreatic islets after viral
infectioninvivo.ResultsindicatethatalthoughRCMVcan
be detected in the pancreas shortly after infection,
pancreatic islets appear to be non-permissive for RCMV
infection. This observation argues against direct cytolytic
infectionofpancreaticb-cellsastheunderlyingmechanism
of RCMV-accelerated onset of diabetes. Since rats are
infected with RCMV by intraperitoneal (i.p.) injection,
we analyzed the possible relation between peritoneal
macrophages(pMF)andacceleratedonsetofdiabetesafter
infection.RCMVinfectionresultedinasigniﬁcantincrease
in the number of pMF shortly after infection. A fraction of
these pMF was infected with RCMV. Depletion of pMF
shortly afterinfectioncompletelyneutralizedtheaccelerat-
ing effect of RCMV on the onset of diabetes.
Taken together, our data indicate that RCMV
accelerates the onset of diabetes without direct cytolytic
infection of pancreatic b-cells. pMF appear to play an
important role in the process leading to accelerated onset
of diabetes since depletion of this population results in
neutralization of the accelerating effect of RCMV.
RESULTS
Diabetes Onset after RCMV Infection
To determine the effect of acute RCMV infection on the
onset of diabetes in DP-BB rats, animals were infected
with 2 £ 10
6pfu RCMVat the age of 35 days. As shown
in Fig. 1, RCMV infection signiﬁcantly accelerated the
onset of diabetes (determined by the presence of
hyperglycaemia; .16mM) compared with both control
groups (p ¼ 0:0164; Kaplan–Meier log rank test). Severe
insulitis, characteristic for the development of auto-
immune diabetes, was detected in pancreatic tissue from
all hyperglycaemic animals (data not shown). Since no
differences were observed in the onset of diabetes in
mock-infected and untreated animals, data from both
groups were pooled.
Presence of RCMV in the Pancreas
To get more insight into the underlying mechanism by
which RCMV accelerates the onset of diabetes, we ﬁrst
analyzed whether RCMV could be detected by speciﬁc
immunohistochemistry in the islets in pancreatic tissue
from animals which had become diabetic after infection.
Since RCMV has a tropism for striated duct epithelial
cells (Kloover et al., 2000), staining on salivary gland
tissue was used as a positive control. In the majority of
the animals, however, only a few RCMV-infected cells
(1–3) were detected in salivary glands, but occasionally
high numbers (20–40) of infected cells were observed
(Fig. 2A). In contrast to the salivary glands, RCMV-
infected cells were never detected within the islets
(Fig. 2B). As shown in Fig. 1, the ﬁrst infected animals
became already diabetic within 15 days after infection.
It has been described that different peripheral organs,
including the pancreas, become infected with RCMV,
but primarily during the systemic phase of infection
(^4 days–2 weeks p.i.) (Bruggeman et al., 1985b). It is
therefore not unlikely that we did not detect infected cells
in pancreatic tissue because at that time the viral
infection had already progressed to its latent phase,
in which infected cells are predominantly detectable in
the salivary glands. We therefore also analyzed
pancreatic tissue for the presence of RCMV 7 days
after infection. From half of the animals ðn ¼ 3Þ
pancreatic islets were isolated, whereas from the
remaining animals whole (non-dissociated) pancreatic
tissue was used. Approximately 120 islets from each
animal were used for DNA isolation. Since we expected
to detect low numbers of infected cells we used a
RCMV-speciﬁc nested PCR to detect viral DNA instead
of less sensitive immunohistochemistry. Seven days p.i.
RCMV was detected after ﬁrst round PCR in non-
dissociated pancreatic tissue from all RCMV-infected
animals (Fig. 2C). As a negative control, the mock-
infected animals were negative for viral DNA. In contrast
FIGURE 1 RCMV-infection (2 £ 10
6pfu) of DP-BB rats at the age of
35 days signiﬁcantly accelerates the onset of diabetes (p ¼ 0:0164;
Kaplan–Meier logrank test). Mock-infected and untreated animals
showed similar onset of diabetes, and therefore data from both groups
were pooled.
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animals showed a weak positive signal after second
round PCR in the isolated pancreatic islet samples (data
not shown). Since the nested PCR used is very sensitive
(approximately 1 RCMV genome copy/800 cells)
(Beisser et al., 1998), these data suggest that although
viral DNA is present in the pancreas 7 days p.i.,
pancreatic islets are relatively non-permissive for
RCMV. The infected cells responsible for the positive
signal in non-dissociated pancreatic tissue are not
identiﬁed yet, but preliminary data suggest that infected
inﬁltrating macrophages rather than infected exocrine
tissue might be the source (data not shown).
Numbers of Peritoneal Macrophages after RCMV
Infection
Data obtained so far suggest that direct cytolytic infection
of pancreatic islets is not the underlying mechanism of
RCMV-accelerated onset of diabetes in DP-BB rats.
Since infected macrophages were occasionally found in
the pancreas early (,1 week) after infection, it is likely
that those cells contribute to the process of accelerated
diabetes development. In our protocol, the standard route
for RCMV-infection is by i.p. injection, and therefore we
analyzed the role of peritoneal macrophages (pMF)i n
RCMV-accelerated onset of diabetes. First we analyzed
the effect of viral infection on the absolute numbers of
pMF that can be retrieved from the peritoneal cavity
(PC) at different time points after infection. As shown in
Fig. 3A, RCMV infection resulted in a signiﬁcant
increase in the number of pMF as rapid as 1 day after
infection (p ¼ 0:036 vs. mock-infection and p ¼ 0:0056
vs. control [no treatment], 2-tailed Mann–Whitney test).
At 3 and 6 days after infection, the numbers of pMF
seemed to restore to normal (control) levels. Since
immunohistochemical staining on cytospots showed that
the cells isolated by peritoneal lavage almost exclusively
consisted of 1C7
þ macrophages at all time points studied
(Fig. 3B), we conclude that the increase of cells 1 day
after infection can be fully attributed to recruitment of
1C7
þ phagocytes into the PC. RCMV-infected cells were
consistently found at all three time-points (Fig. 3C), but
the numbers were low (,0.05% of pMF). However, as
will be discussed later, immunohistochemical detection
of RCMV IE-antigens with Mab 8 may have resulted in a
signiﬁcant underestimation of the actual number of
RCMV infected pMF.
FIGURE 3 RCMV-infection results in increased numbers of pMF.
Animals were i.p. infected with RCMV (2 £ 10
6pfu), mock-infected or
left untreated (control) and on days 1, 3 and 6 p.i. peritoneal lavage was
performed and the number of cells were counted. (A) RCMV-infection
resulted in a signiﬁcant increase in the number of pMF 1 day after
infection (p ¼ 0:036 vs. mock infection and p ¼ 0:0056 vs. control,
2-tailed Mann–Whitney test). At the later time-points the number of
pMF restored back to normal levels. (B) Photomicrograph of cells
isolated by peritoneal lavage. The cell population almost exclusively
consisted of 1C7
þ macrophages (original magniﬁcation: £ 400).
(C) Photomicrograph of cells isolated by peritoneal lavage containing
mAb8
þ RCMV-infected cells (arrows) (original magniﬁcation: £ 400).
FIGURE 2 Detection of RCMV by immunohistochemistry and PCR
analysis in salivary gland and pancreas of infected animals.
(A) Photomicrograph showing RCMV-infected epithelial cells in the
salivary gland of a diabetic DP-BB rat, 4 weeks after infection (original
magniﬁcation: £ 400). (B) Photomicrograph of pancreatic tissue of a
diabetic DP-BB rat showing absence of RCMV-infected cells in islets
4 weeks after infection (original magniﬁcation: £ 400). (C) RCMV-
speciﬁc PCR analysis performed on non-dissociated pancreatic tissue
from3 RCMV-infected(1–3)and 3mock-infected (4–6)rats7daysafter
infection. All samples from RCMV-infected animals show the RCMV-
speciﬁc PCR product, indicatingthat viral DNA is present in the pancreas
7 days after infection.
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Infection
Since we showed that i.p. RCMV-infection results in
increased numbers of peritoneal macrophages of which
some are productively infected, we determined the effect
of depleting macrophages “early” (days 1–3) and “late”
(days 6–8) after infection on the RCMV-induced
accelerated onset of diabetes. As is shown in Fig. 4,
depletion of macrophages “early” after infection com-
pletely neutralized the RCMV-induced acceleration of
diabetes development, and no signiﬁcant differences were
observed between RCMV-infected animals and mock-
infected animals. (Data from mock-infected animals were
pooled since no differences in the onset of diabetes were
observed between “early” and “late” lavaged mock-
infected animals). Peritoneal lavage on days 6 and 8 after
infection, however, did not neutralize the accelerating
effect of RCMV: animals undergoing “late” lavage still
showed accelerated onset of diabetes compared to the
mock-infected and “early” lavage RCMV-infected rats
(p ¼ 0.0056 and 0.0223, respectively, Kaplan–Meier log
rank test).
DISCUSSION
Natural perturbants like viral infections are believed to
play a role in the pathogenesis of Type 1 diabetes. One of
the candidate viruses is CMV, a herpes virus with a
widespread distribution (Numazaki, 1997). Although
some correlative studies on CMV and Type 1 diabetes
have been reported, it turns out to be very difﬁcult to show
any causative relationship (Ward et al., 1979; Banatvala
et al., 1985; Pak et al., 1988; Foulis et al., 1997). Recently,
we described an animal model for Type 1 diabetes in
which a direct association between CMV infection and
onset of diabetes was observed: RCMV infection of
DP-BB rats (which develop Type 1 diabetes spon-
taneously at the age of 10–14 weeks) resulted in
accelerated onset of disease.
In this paper, we addressed the question what the
mechanism could be behind this phenomenon of virus-
induced accelerated onset of diabetes. One explanation
might be that RCMV infection results in direct cytolytic
destruction of pancreatic b-cells. Here we showed,
however, that RCMV antigens could not be detected in
the islets from infected diabetic rats, and we were only
able to demonstrate presence of viral DNA in isolated
pancreatic islets in 1 out of 3 samples. These data suggest
that islets are non-permissive for RCMV infection and in
line with this, preliminary data suggest that also cultured
islets are non-permissive for RCMV infection in vitro
(data not shown). Non-permissiveness of islets and b-cells
for CMV infection has also been reported for human CMV
(HCMV); only 1–2% of the b-cells in cultured fetal islets
become infected after culturing in the presence of HCMV
without direct destruction of the b-cells (Numazaki et al.,
1988, 1990). In addition, we showed that both co-isogenic
Diabetes Resistant (DR)-BB rats as well as other rats
strains tested do not develop diabetes after RCMV
infection (J.L. Hillebrands, submitted). Taken together,
these data indicate that direct cytolytic infection of
pancreatic b-cells is not the mechanism by which RCMV
accelerates the onset of diabetes.
Since RCMV-infected macrophages could be detected
in pancreatic tissue (primarily located in the interlobular
spaces) shortly after i.p. infection (,1w e e k ) ,w e
wondered whether these cells are involved in the
pathogenetic process of RCMV-induced acceleration of
diabetes onset in DP-BB rats. As in our protocol, the
standard route for administration of virus to achieve
systemic RCMV infection is by i.p. injection (Bruggeman
et al., 1985b).Since the PC contains considerable numbers
of leukocytes, predominantly consisting of resident
macrophages (peritoneal macrophages, pMF) (Hendrix
et al., 1986), we studied the role of this macrophage subset
in accelerated diabetes development. By analyzing the
absolute numbers of pMF isolated by peritoneal lavage at
different time points after infection, we showed that 1 day
after infection the number of pMF present in the PC is
signiﬁcantly increased, most likely as a result of
recruitment of mononuclear cells into the peritoneum.
This increase in pMF numbers in response to RCMV
infection was previously reported by Engels et al. who
moreover showed that this inﬂux of mononuclear cells
was preceded by an inﬂux of polymorphonuclear
granulocytes (PMN), reaching maximum numbers already
2h after infection (Engels et al., 1989). At 1 day after
infection we also observed increased numbers of PMN’s,
but the vast majority of isolated cells at this time point
consisted of macrophages as determined by speciﬁc
immunohistochemistry. At days 3 and 6 we observed a
decrease in cell counts back to normal levels suggesting
FIGURE 4 Depletion of pMF “early” after RCMV infection
completely neutralizes the RCMV-induced acceleration of diabetes
development. Animals were infected with RCMV (2 £ 10
6pfu) or
mock-infected. At “early” (days 1 and 3) and “late” (days 6–8) time
points after infection, pMF were depleted by peritoneal lavage and the
animals were followed for diabetes development. Peritoneal lavage “late”
after infection did not neutralize the accelerating effect and animals
developed diabetes in an accelerated fashion compared to the mock-
infectedand“early”lavage RCMV-infected rats(p ¼ 0.0056and0.0223,
respectively, Kaplan–Meier log rank test).
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could detect infected pMF using immunohistochemical
detection of RCMV IE-antigens, although the percentages
were low (,0.05%). This suggests that almost no
reproductive infection occurs in pMF (Engels et al.,
1989). This does not exclude the possibility that many
cells have taken up virus, however, without subsequent
viral replication (i.e. the cells become latently infected).
For HCMV it has been shown that monocytes can become
latently infected without viral reproduction, and such cells
are believed to play an important role in virus
dissemination (Sinclair and Sissons, 1996; Michelson,
1997). Without having productive viral replication
themselves, HCMV-infected monocytes have been
shown to be able to transfer virus to more permissive
cell types like ﬁbroblasts (Waldman et al., 1995).
Moreover, HCMV can be reactivated (resulting in viral
replication) if latently infected monocytes are activated
and differentiate into macrophages (Ibanez et al., 1991).
That pMF in infected DP-BB rats play an important
role in the accelerated development of diabetes is shown
by the fact that depletion of these cells early after infection
results in complete neutralization of the accelerating effect
of RCMV. It is unlikely that this is due to the removal of
free, non-cellbound, virus from the PC since it has been
demonstrated that RCMV is almost completely cleared
from peritoneal lavage ﬂuid within 8h after i.p. infection
(Bruggeman et al., 1985a). Plaque-assays performed on
lavage ﬂuid isolated 1 day after infection conﬁrmed the
absence of non-cellbound virus (data not shown).
Based on the data described in this study we conclude
that pMF play an important role in RCMV-induced
acceleration of diabetes onset. The increased inﬂux of
mononuclear cells in the PC followed by restoration to
normal levels suggest migration of (infected) cells
throughout the body. Since preliminary data indicate that
there is accumulation of infected macrophages in the
pancreas, we suggest that these infected pMF are
preferentially attracted to the pancreas. Since autoreactive
T cells play a central role in the development of Type I
diabetes, we propose that such RCMV infected pMF will
further activate and recruite autoreactive T cells, thereby
accelerating the diabetogenic process. This has been
shown for a pancreatropic Coxsackievirus in NOD mice in
which infection resulted in accelerated onset of diabetes if
the b-cell autoreactive T cells had already accumulated in
and around the islets at the time of viral infection (Serreze
et al., 2000). Besides this non-virus speciﬁc activation of
autoreactive T cells, a virus-speciﬁc component might be
involved. Recent data indicate that RCMV induces a very
strong T cell proliferative response resembling the
response pattern after polyclonal stimulation, leaving the
possibility open that RCMV might directly activate
autoreactive T cells resulting in accelerated onset of
diabetes (van der Werf et al., this issue).
Future studies will be directed at characterizing the
factor(s) responsible for (preferential) migration of
infected pMF to the pancreas. In addition, functional
analyses on the interaction between infected macro-
phages and (autoreactive) T cells are needed to further
elucidate the mechanism by which RCMVaccelerates the
onset of diabetes.
MATERIALS AND METHODS
Animals
Diabetes Prone (DP-BB/Wor) BB rats were bred at the
central animal facility of the University of Groningen, The
Netherlands. The breeding stock was originally provided
by the University of Massachusetts, Worcester, MA, USA.
The animals were raised under speciﬁc-pathogen-free
(SPF) and viral-antibody-free (VAF) conditions and had
access to water and food ad libitum. The experiments
described in this study were approved by the university
Ethical Board for Animal Studies.
Infection with RCMV
For viral infection, 35 days old male and female DP-BB
rats were injected intraperitoneally with 1ml saline
containing 2 £ 10
6pfu RCMV (Maastricht strain). The
RCMV-stock consisted of salivary gland homogenates
obtained from infected rats and prepared as described
elsewhere (Bruggeman et al., 1982). Control rats were
mock-infected or left untreated. Mock-infection was
established by i.p. injection of 1ml saline containing an
equal amount of salivary gland homogenate as for
RCMV, but now prepared from tissue obtained from non-
infected rats.
Experimental Setup
To study the effect of RCMV-infection on the onset of
diabetes, DP-BB rats were RCMV-infected ðn ¼ 20Þ;
mock-infected ðn ¼ 10Þ or left untreated ðn ¼ 10Þ:
Diabetic rats were killed at diagnosis and non-diabetic
animals were killed at the end of the follow-up period
(age 120 days). Pancreas and salivary glands were
removed and processed for RCMV-speciﬁc immuno-
histochemistry. To analyze whether RCMV is able to
infect pancreatic islets rats were RCMV ðn ¼ 6Þor mock-
infected ðn ¼ 6Þ: Seven days after infection, pancreatic
islets were isolated from three animals in each group,
whereas from the other three animals complete (non-
dissociated) pancreatic tissue was removed. Isolated islets
and pancreatic tissue were subsequently analyzed for the
presence of viral DNA using a RCMV-speciﬁc PCR. To
study the role of pMF in RCMV-modulated onset of
diabetes, the number of retrievable pMF from the PC by
lavagewas determined at severaltime-points(days 1,3 and
6) after RCMV- and mock-infection. Moreover, immuno-
histochemistry for macrophages and RCMV was
performed on these isolated cells. To analyze whether
removal of pMF inﬂuences the onset of diabetes after
viral infection, pMF were removed early (days 1 and 3)
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After the second lavage animals were followed for
diabetes development.
Diabetes
Animals were monitored twice a week for physical well-
being and weight loss. If weight loss was detected, the
animals were checked for hyperglycemia by glucose
measurements in tail vein blood using a Reﬂolux
wS
glucose sensor (Boehringer Mannheim, Germany). If
glucose levels exceeded 16mM (288mg/dl) animals were
considered diabetic.
Isolation of Pancreatic Islets
Pancreatic islets were isolated as described elsewhere
(de Vos et al., 1997). Brieﬂy, after distending the pancreas
with Krebs–Ringer–Hepes buffer the pancreas was
excised, chopped and subsequently digested using
incubation with collagenase (Sigma type XI, Sigma,
USA). Islets were separated from exocrine tissue by
centrifugation over a discontinuous dextran gradient and
further puriﬁed by handpicking. The yield of pancreatic
islets was approximately 225 islets per pancreas.
Isolation of Peritoneal Macrophages (pMF)
Peritoneal macrophages were retrieved from the PC by
lavage. Therefore, 10ml sterile salinewas injected into the
PC. After spreading the saline throughout the PC by
abdominal massage, the injected ﬂuid was retrieved with a
16 gauge canula via a small incision (3mm) after which
the wound was closed with one suture. Generally, a
volume of at least 8ml was retrieved using this method.
After centrifuging the cells (1200rpm, 10min) pellets
were resuspended in PBS, counted and adjusted to a
concentration of 5 £ 10
5 cells per ml. Finally, cells were
spun onto glass slides (75 £ 10
3 cells/spot) using a
Cytospin (Shandon, United Kingdom), air dried, ﬁxed in
acetone for 10min at room temperature and stored until
immunohistochemical staining.
Histologic Analysis
For detection of RCMV antigens, 7mm Bouin-ﬁxed
parafﬁn embedded tissue sections (pancreas and salivary
gland) were stained with RCMV monoclonal antibody
(mAb 8) (Bruning et al., 1987). Brieﬂy, after deparafﬁna-
tion tissue sections were incubated with mAb8 for 60min.
Subsequently, sections were incubated with a second step
horseradish peroxidase or alkaline-phosphatase conju-
gated rabbit anti-mouse antibody (DAKO A/S, Denmark)
for 30min. The chromogens diaminobenzidine (DAB) or
Fast-Red were applied for 30min, and subsequently
sections were counterstained with Mayer’s hematoxylin
and cover slipped. For staining of pMF, cytospots were
aceton-ﬁxed and stained for macrophages and RCMV
(mAb’s 1C7 (van Goor et al., 1988) and mAb8,
respectively) as described above.
Detection of RCMV DNA
To determine the presence of viral DNA in pancreatic
tissue or isolated pancreatic islets, DNAwas isolated using
a DNA extraction kit (DNeasy Tissue Kit, Qiagen,
Westburg B.V., The Netherlands). Subsequently, RCMV-
speciﬁc (nested) PCR analysis was performed. The primer
sequences and PCR conditions are described elsewhere
(Beisser et al., 1998). Second-round PCR was only
performed on those samples that were negative after the
ﬁrst-round PCR. PCR products were analyzed by agarose
gel electrophoresis and visualized by ethidium bromide
staining.
Statistical Analysis
To detect signiﬁcant differences in diabetes onset, the
Kaplan–Meier log rank test was performed. The 2-tailed
Mann–Whitney test was performed to test for signiﬁcant
differences in numbers of peritoneal macrophages.
Differences were considered signiﬁcant when p , 0:05:
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